Clinical as well as preclinical experimental studies show that Toll-like receptor 4 (TLR4) expression and activation is directly associated with obesity-induced tissue inflammation; abrogation of TLR4 is able to reverse insulin resistance and pancreatic β-cell dysfunction in experimental models7–14. The gene discussed is TLR4; the disease is obesity due to melanocortin 4 receptor deficiency.